Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Nitrous oxide [1] Nitrous oxide[2] MEOPA; Nitrous Oxide; --[2] 34, 149
2 Baclofen [1] Baclofen[2] BACLOFEN; Kemstro; [2] GABBR1,
GABBR2 💬		[7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[8] 2, 10, 13, 18, 65, 70, 149, 206
3 Botulinum toxin type A [1] Botulinum toxin type A[8] Botox; Botulinum toxin A; BOTULINUM TOXIN TYPE A; BTX-A; Dysport; IncobotulinumtoxinA; OnabotulinumtoxinA; Xeomin; [1] SNAP25 💬[2] Insulin secretion, Synaptic vesicle cycle 💬[14] 2, 5, 6, 7, 13, 15, 17, 36, 47, 51, 70, 113, 149, 226
4 Sodium oxybate [1] Sodium oxybate[1] Sodium Oxybate; --[2] 6, 149
5 Lacosamide [1] Lacosamide[1] Lacosamide; [2] SCN3A,
SCN9A 💬		[1] Taste transduction 💬[4] 2, 46, 149, 298
6 Fenfluramine [1] Fenfluramine[2] Fenfluramina; Fenfluramine; [5] HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		[10] Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[4] 140, 144, 145, 149
7 Flunarizine [1] Flunarizine[0] [3] CACNA1G,
CACNA1H,
CACNA1I 💬		[8] Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus 💬[1] 149
8 Brivaracetam [1] Brivaracetam[1] Brivaracetam; [1] SV2A 💬[1] ECM-receptor interaction 💬[2] 149, 309
9 Triheptanoin [1] Triheptanoin[1] TRIHEPTANOIN; --[10] 2, 8, 65, 149, 156, 248, 256, 257, 317, 324
10 Padsevonil [1] Padsevonil[1] Padsevonil; [3] SV2A,
SV2B,
SV2C 💬		[1] ECM-receptor interaction 💬[1] 149